瘤免疫微环境在肝内胆管癌:调控机制,功能和治疗影响
Angela Dalia Ricci1, Alessandro Rizzo2, Annalisa Schirizzi3
1Medical Oncology Unit, National Institute of Gastroenterology, IRCCS "S. de Bellis" Research Hospital, 70013 Castellana Grotte, Italy.
Cancers
|October 26, 2024
概括
肝脏内胆管癌 (iCCA) 治疗正在通过免疫疗法得到改善. 了解瘤免疫微环境 (TIME) 是提高免疫检查点抑制剂 (ICI) 的有效性和改善iCCA患者的生存率的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肝胆道医学 肝胆道医学
背景情况:
- 肝脏内胆管癌 (iCCA) 是一种恶性肝脏瘤,治疗选择有限,预后不佳.
- 免疫治疗的最新进展,特别是免疫检查点抑制剂 (ICI),为iCCA提供了新的治疗途径.
- 在确定ICI反应的生物标志物和优化基于免疫的组合疗法方面仍然存在挑战.
研究的目的:
- 在iCCA中审查瘤免疫微环境 (TIME) 的作用.
- 讨论提高ICI在iCCA中的有效性的策略.
- 探索iCCA免疫疗法的未来研究方向.
主要方法:
- 文献综述侧重于iCCA和瘤免疫微环境.
- 分析当前免疫治疗方法和挑战.
- 讨论新出现的治疗目标和治疗策略.
主要成果:
- 时间显著影响了iCCA对免疫治疗的反应.
- 针对免疫学上"冷"的ICCA瘤进行"升温"的策略对于ICI疗效至关重要.
- 识别预测生物标志物和新的治疗组合是必不可少的.
结论:
- 针对TIME对于推进iCCA免疫疗法至关重要.
- 进一步研究新的标和治疗计划可以提高iCCA患者的生存率.
- 组合疗法有望克服耐药性并提高治疗结果.
更多相关视频
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
486
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
486